Hematologist-Oncologist Guilherme Rabinowits, M.D., Joins Miami Cancer Institute
MIAMI, FL – February 28, 2018 — Miami Cancer Institute, part of Baptist Health South Florida and the state’s only member of the Memorial Sloan Kettering Cancer Alliance, welcomes hematologist-oncologist Guilherme Rabinowits, M.D., to its world-class, multidisciplinary team of cancer care specialists. Dr. Rabinowits specializes in the diagnosis and treatment of head and neck cancer, melanoma, and non-melanoma skin cancer. He is a recognized expert in the treatment of Merkel cell carcinoma — a rare skin cancer. He is conducting several clinical trials to study this disease, increasing translational research efforts for the management of the aggressive cancer. He has led the development of Head and Neck Oncology Pathways, which guides oncology practitioners in the delivery of evidence-based treatment for head and neck cancer.
“Dr. Rabinowits brings to the Institute significant training and experience in hematology and oncology and the treatment of rare and aggressive cancers,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “His clinical expertise and leadership in research and teaching will greatly benefit our team and patients with head and neck cancer, melanoma, and non-melanoma skin cancer.”
Dr. Rabinowits is an editorial reviewer for several peer-reviewed scientific journals and teaches medical oncology to students, residents and fellows. He served as a member of Harvard Medical School’s clinical faculty for six years. He is widely published in numerous medical journals and is invited to present at scientific conferences. He is a member of the America Society of Clinical Oncology.
Dr. Rabinowits is Board certified in internal medicine, medical oncology and hematology. He received his medical degree from Fundacao Tecnico-Educacional Souza Marques in Rio de Janeiro, Brazil. He completed a residency in internal medicine at Lahey Clinic and Medical Center in Burlington, Mass. His post-doctoral training also includes an oncology-hematology fellowship at the University of Louisville in Louisville, Ky., where he served as chief fellow.
Dr. Rabinowits comes to Miami Cancer Institute from Dana-Farber Cancer Institute and Brigham and Women’s Hospital, both located in in Boston, Mass.
About Miami Cancer Institute
Baptist Health South Florida is developing Miami Cancer Institute into a destination cancer center known for its leading clinical care, compassionate patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a meaningful partnership that affords patients with cancer access to potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with ten hospitals (Baptist Hospital, Baptist Children’s Hospital, Bethesda Hospital East, Bethesda Hospital West, Doctors Hospital, Fishermen’s Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 40 physician practices, 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence spanning across Monroe, Miami-Dade, Broward and Palm Beach counties. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 18,500 employees and more than 3,000 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
# # #
